These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10798283)

  • 21. The thoughts of breast cancer survivors regarding the need for starting hormone replacement therapy.
    Trinh XB; Peeters F; Tjalma WA
    Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):250-3. PubMed ID: 16144734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmenopausal hormone therapy and the risk of venous thromboembolism.
    Rachoń D; Teede H
    Climacteric; 2008 Aug; 11(4):273-9. PubMed ID: 18645692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Contraceptives and breast cancer (author's transl)].
    Mauvais-Jarvis P; Kuttenn F
    Contracept Fertil Sex (Paris); 1976 Sep; 4(5):343-8. PubMed ID: 992191
    [No Abstract]   [Full Text] [Related]  

  • 24. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone replacement therapy and risk of breast cancer: the role of progestins.
    Stahlberg C; Pedersen AT; Lynge E; Ottesen B
    Acta Obstet Gynecol Scand; 2003 Apr; 82(4):335-44. PubMed ID: 12716318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hormone replacement therapy in patients after breast cancer].
    Köninger A; Kümmel S; Kimmig R
    MMW Fortschr Med; 2008 Oct; 150(43):32-4. PubMed ID: 19025144
    [No Abstract]   [Full Text] [Related]  

  • 28. Estrogen and the skin.
    Murase JE; Wu JJ; Weinstein GD
    J Am Acad Dermatol; 2006 Dec; 55(6):1115-6. PubMed ID: 17110232
    [No Abstract]   [Full Text] [Related]  

  • 29. Exogenous sex hormones and risk of breast cancer.
    Smetnik V; Konovalova V
    Gynecol Endocrinol; 2010 Mar; 26(3):149-51. PubMed ID: 19626508
    [No Abstract]   [Full Text] [Related]  

  • 30. HRT 2000: pause for thought.
    Harv Womens Health Watch; 2000 Apr; 7(8):1-3. PubMed ID: 10712769
    [No Abstract]   [Full Text] [Related]  

  • 31. Women seek alternatives to hormone replacement therapy.
    Altern Ther Health Med; 2002; 8(5):27. PubMed ID: 12233798
    [No Abstract]   [Full Text] [Related]  

  • 32. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
    Stjernquist M;
    Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer. Estrogen's long-term influence.
    Harv Womens Health Watch; 1999 Mar; 6(7):6. PubMed ID: 10066320
    [No Abstract]   [Full Text] [Related]  

  • 34. [Estrogens or progestational agents?].
    de Lignières B
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(5):579-80. PubMed ID: 6491200
    [No Abstract]   [Full Text] [Related]  

  • 35. HRT and breast cancer: impact on population risk and incidence.
    Coombs NJ; Taylor R; Wilcken N; Boyages J
    Eur J Cancer; 2005 Aug; 41(12):1775-81. PubMed ID: 16087330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability of breast cancer risk in observational studies of hormone replacement therapy: a meta-regression analysis.
    Garbe E; Levesque L; Suissa S
    Maturitas; 2004 Mar; 47(3):175-83. PubMed ID: 15036487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy.
    Santen RJ; Pinkerton J; McCartney C; Petroni GR
    J Clin Endocrinol Metab; 2001 Jan; 86(1):16-23. PubMed ID: 11231971
    [No Abstract]   [Full Text] [Related]  

  • 38. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term hormone substitution and risk of breast carcinoma: current status].
    Kuhl H; Runnebaum B; Schneider HP
    Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):M1-5. PubMed ID: 8852790
    [No Abstract]   [Full Text] [Related]  

  • 40. [Estrogen replacement therapy and breast cancer].
    Bakken K; Alsaker E; Eggen AE; Lund E
    Tidsskr Nor Laegeforen; 2005 Feb; 125(3):282-5. PubMed ID: 15702147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.